Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid
about
Aristolochic acid-associated urothelial cancer in TaiwanConsensus statement on screening, diagnosis, classification and treatment of endemic (Balkan) nephropathyChinese herbs containing aristolochic acid associated with renal failure and urothelial carcinoma: a review from epidemiologic observations to causal inferenceAnalysis of TP53 mutation spectra reveals the fingerprint of the potent environmental carcinogen, aristolochic acidBalkan endemic nephropathy: an update on its aetiologyMechanisms of enzyme-catalyzed reduction of two carcinogenic nitro-aromatics, 3-nitrobenzanthrone and aristolochic acid I: Experimental and theoretical approachesAn Integrated View of Aristolochic Acid Nephropathy: Update of the LiteratureLinking DNA adduct formation and human cancer risk in chemical carcinogenesis.PRESENCE OF CITRININ IN GRAINS AND ITS POSSIBLE HEALTH EFFECTS.Medicinally Used Asarum Species: High-Resolution LC-MS Analysis of Aristolochic Acid Analogs and In vitro Toxicity Screening in HK-2 Cells.Bioactivation of the human carcinogen aristolochic acidFormalin-fixed paraffin-embedded tissue as a source for quantitation of carcinogen DNA adducts: aristolochic acid as a prototype carcinogenUnambiguous detection of multiple TP53 gene mutations in AAN-associated urothelial cancer in Belgium using laser capture microdissectionEvaluating weight of evidence in the mystery of Balkan endemic nephropathy.Genome-wide mutational signatures of aristolochic acid and its application as a screening tool.Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing.Chronic dietary exposure to aristolochic acid and kidney function in native farmers from a Croatian endemic area and Bosnian immigrants.An integrated system for identifying the hidden assassins in traditional medicines containing aristolochic acids.New Approaches for Biomonitoring Exposure to the Human Carcinogen Aristolochic Acid.Renal cell carcinomas of chronic kidney disease patients harbor the mutational signature of carcinogenic aristolochic acid.Biomonitoring of aristolactam-DNA adducts in human tissues using ultra-performance liquid chromatography/ion-trap mass spectrometry.Low-Coverage Exome Sequencing Screen in Formalin-Fixed Paraffin-Embedded Tumors Reveals Evidence of Exposure to Carcinogenic Aristolochic Acid.Risk assessment of upper tract urothelial carcinoma related to aristolochic acid.Multiclass Carcinogenic DNA Adduct Quantification in Formalin-Fixed Paraffin-Embedded Tissues by Ultraperformance Liquid Chromatography-Tandem Mass Spectrometry.Mass spectrometry of structurally modified DNA.Sulfotransferase-1A1-dependent bioactivation of aristolochic acid I and N-hydroxyaristolactam I in human cells.Human formalin-fixed paraffin-embedded tissues: an untapped specimen for biomonitoring of carcinogen DNA adducts by mass spectrometry.Toxicological actions of plant-derived and anthropogenic methylenedioxyphenyl-substituted chemicals in mammals and insects.Aristolochic acid nephropathy: Harbinger of a global iatrogenic disease.Knockout and humanized mice as suitable tools to identify enzymes metabolizing the human carcinogen aristolochic acid.Naturally occurring aristolochic acid analogues and their toxicities.Aristolochic Acid in the Etiology of Renal Cell Carcinoma.Bacillus Calmette-Guerin therapy in non-muscle-invasive bladder carcinoma after renal transplantation for end-stage aristolochic acid nephropathy.Human Biomonitoring of DNA Adducts by Ion Trap Multistage Mass SpectrometryAnalysis of potential risk factors for cancer incidence in patients with aristolochic acid nephropathy from Wenzhou, China.Aristolochia clematitis, the herb responsible for aristolochic acid nephropathy, in an uncultivated piece of land of an Italian nephrologist.A fluorescence-based analysis of aristolochic acid-derived DNA adducts.The influence of ochratoxin A on DNA adduct formation by the carcinogen aristolochic acid in rats.Trends in incidence and prevalence of Balkan endemic nephropathy in the three most affected villages in Serbia over a 36-year period.Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: clinical characteristics and outcomes.
P2860
Q24616582-79284B34-DF7E-46D9-8BC6-C7DB022C53D4Q26827750-2C61FBB2-EA3A-467E-A4E0-A843D6581182Q26995515-9EB98424-6697-4D2E-A2CE-B1BD2B49C7DFQ27021933-22FF64B5-F595-4142-927F-5ECAACF3C264Q28079308-6594E7DF-CD20-4EFA-849B-BAC17A77A4E4Q28390347-A1006B9B-DC8D-463A-B872-3AC6346E04FAQ30238670-933A6553-43AB-4EA2-80B8-03CCBF9E4834Q30249312-A0640559-93F6-46A7-BD51-96564EE4EFD3Q33624052-48D5872B-3AF7-43A2-949F-60C29792C686Q33710924-7DA8CC67-312F-4CB7-8DB0-D9B74D7CE429Q34009989-2E2BD2CA-85F0-44F2-8265-F6BA2B9C0F57Q34096814-C010BFE1-3D64-46E6-A4B6-A28558A2189BQ34128720-2A1B3190-F9F2-46DF-9978-85EC16E8BD57Q34353066-AAA6545D-66E9-4CB9-BD88-685B7AA29F93Q34362611-D7CF4EBC-EB79-4BB3-8E2B-D083296E9DAEQ34362617-08CEDDB4-0C2D-4161-B636-974B76AA8D04Q35051174-78D33121-F8D8-4886-A54A-B701E63F617CQ35949324-DF2BEFEA-7CE0-4D19-A5B4-53E53F7E20B6Q36041371-A3621362-E007-42A4-B2DA-D8087FB93774Q36485385-15A6EA02-434A-49F8-A8DF-C8C599FA4200Q36505864-A2580D8A-AD66-4FA5-87F0-E6F9CAC07FFDQ36725046-1E5380FF-C218-4BF9-9D29-03C910A066A1Q36831822-DC668803-CFEC-43CE-9731-C7E282AA7DC6Q36863315-58F0B99F-D754-4F1D-90D9-684007D5BE6BQ36979806-641E3388-4F0B-4681-9E22-CB7EA9F2B70CQ37074055-C2BE80EF-41DE-49B3-A2EB-7D172387F0A8Q37523243-8E95739E-CD60-4BEC-B0D4-1DB4C3EDA896Q38039138-A5146593-4019-4D1F-BF59-DFDC24677BA8Q38067278-AC7D051C-9B82-402C-BFA4-8E3CD029822EQ38154957-254742EB-99A3-4873-B4C8-17EBD7EC6C8EQ38201308-D0DBF447-19A0-4E32-B917-A0475365EB85Q39459925-E78DD6BC-CACD-4DD2-9AE3-C620C8181C96Q40183879-19CCB7F4-BB31-4C95-9C5D-40FAE150ECD4Q41121404-53F66199-13C7-40B2-A056-65E29E96A37CQ41649479-D1D35788-E479-44FD-BF91-D0DEDC4AE28DQ41744877-2A828E8F-4607-42BE-86F1-23727BFF5927Q41828256-5038C4A7-95D3-4B29-B67C-701122C8695AQ42704240-E63B48E1-2EFC-409F-A673-B35BB6336071Q43499799-8112E9FE-460E-4EDA-96AF-99F8C1BE2CB8Q44323061-09E68CF9-8071-4DB6-B71D-EF869700E0F2
P2860
Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid
@ast
Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid
@en
type
label
Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid
@ast
Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid
@en
prefLabel
Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid
@ast
Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid
@en
P2093
P2860
P356
P1433
P1476
Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid
@en
P2093
Arthur P Grollman
Bojan Jelaković
Branko Brdar
Damir Dittrich
Frederick Miller
Ivana Vuković-Lela
Jovan Nikolić
Karen L Edwards
Karla Tomić
Kathleen G Dickman
P2860
P2888
P304
P356
10.1038/KI.2011.371
P407
P577
2011-11-09T00:00:00Z